https://www.selleckchem.com/pr....oducts/sb290157-tfa.
Evaluate the safety and efficacy of epi-off corneal cross-linking (CXL) in adolescents with progressive keratoconus (KC). Private clinical practice DESIGN Nonrandomized prospective clinical trial METHODS 230 adolescent patients aged 10-19 years old with progressive keratoconus (increasing maximum keratometry (Kmax) or astigmatism of ≥ 1 D associated with decreased corrected distance visual acuity (CDVA)) underwent CXL. Exclusion criteria were age at time of CXL 10 years or 19 years, corneas that were thinner than 400 μm o
Like
Comment
Share
